TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2012

Phase-I/II study of bortezomib in combination with carboplatin and bevacizumab as first-line therapy in patients with advanced non-small-cell lung cancer.

Bilal Piperdi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.